Yes C totally agree. I remember Glitts having a light bulb moment during our discussions. Some did talk and if they had converted the 5m oppies and kept them they would be $1.5m up today with huge more upside.
l remember a very early German study on long covid found both cardio and brain effects in younger cohorts who had not been hospitalized. The cardiol or 675 may head there one day.
The derisking imo will be completed upon results of the first human trial, hopefully OSA followed by 675 with a plan to get there.
Many of us here have stuck by each other and the company with a vision of the big picture in terms of beneficial human result outcomes as well
as the financial reward in backing the science over the fluff we often see.
Great to be on this journey with all the long termers. Our collective patience l believe will pay off in many ways.
Best wishes mate!
General discussion, page-5817
-
- There are more pages in this discussion • 14,370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)